Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carditis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Carditis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischlein, T; Förch, S; Juchem, G; Knott, M; Kreuzer, E; Laufer, S; Nees, S; Reichart, B; Senftl, A; Weiss, DR1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carditis

ArticleYear
Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models.
    American journal of physiology. Heart and circulatory physiology, 2012, Feb-01, Volume: 302, Issue:3

    Topics: Actins; Arterioles; Blood Platelets; Blood Proteins; Capillaries; Capillary Permeability; Cells, Cultured; Coronary Circulation; Dinoprostone; Drug Synergism; Endothelial Cells; Erythrocytes; Hemostatics; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Leukotriene B4; Myocarditis; Pericytes; Platelet Activating Factor; Thrombin; Venules

2012